Clinical characteristics of probands with obsessive-compulsive disorder from simplex and multiplex families

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
RAMOS, Vanessa R.
OLIVEIRA, Melaine C.
V, Thomas Fernandez
CROWLEY, James J.
STORCH, Eric A.
Citação
PSYCHIATRY RESEARCH, v.331, article ID 115627, 8p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Genetic and non-genetic factors contribute to obsessive-compulsive disorder (OCD), with strong evidence of familial clustering. Genomic studies in psychiatry have used the concepts of families that are ""simplex"" (one affected) versus ""multiplex"" (multiple affected). Our study compares demographic and clinical data from OCD probands in simplex and multiplex families to uncover potential differences. We analyzed 994 OCD probands (501 multiplex, 493 simplex) from the Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders (C-TOC). Clinicians administered the Structured Clinical Interview for DSM-IV (SCID-IV) to diagnose, Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) to assess severity, and Dimensional Yale-Brown ObsessiveCompulsive Scale (DY-BOCS) to assess symptom dimensionality. Demographics, clinical history, and family data were collected. Compared to simplex probands, multiplex probands had earlier onset, higher sexual/religious and hoarding dimensions severity, increased comorbidity with other obsessive-compulsive-related disorders (OCRD), and higher family history of psychiatric disorders. These comparisons provide the first insights into demographic and clinical differences between Latin American simplex and multiplex families with OCD. Distinct clinical patterns may suggest diverse genetic and environmental influences. Further research is needed to clarify these differences, which have implications for symptom monitoring and management.
Palavras-chave
Obsessive-compulsive disorder, Family history, Clinical differences, Latin America
Referências
  1. Alemany-Navarro M, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0804-z
  2. Alsobrook JP, 1999, AM J MED GENET, V88, P669, DOI 10.1002/(SICI)1096-8628(19991215)88:6<669::AID-AJMG17>3.0.CO;2-N
  3. American Psychiatric Association D.S. Association, 2013, Diagnostic and Statistical Manual of Mental Disorders: DSM-5
  4. [Anonymous], 2022, Nat Rev Psychol, V1, DOI [10.1038/s44159-022-00087-3,369, DOI 10.1038/S44159-022-00087-3,369]
  5. Arnold PD, 2018, MOL PSYCHIATR, V23, P1181, DOI 10.1038/mp.2017.154
  6. Berends D, 2019, J AUTISM DEV DISORD, V49, P3401, DOI 10.1007/s10803-019-04052-7
  7. Bienvenu OJ, 2000, BIOL PSYCHIAT, V48, P287, DOI 10.1016/S0006-3223(00)00831-3
  8. Blanco-Vieira T, 2023, TRANSL PSYCHIAT, V13, DOI 10.1038/s41398-023-02433-2
  9. Brakoulias V, 2017, COMPR PSYCHIAT, V76, P79, DOI 10.1016/j.comppsych.2017.04.002
  10. Brakoulias V, 2016, PSYCHIAT RES, V239, P315, DOI 10.1016/j.psychres.2016.03.047
  11. Bralten J, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0793-y
  12. Brander G, 2021, MOL PSYCHIATR, V26, P1224, DOI 10.1038/s41380-019-0532-z
  13. Browne HA, 2015, JAMA PSYCHIAT, V72, P359, DOI 10.1001/jamapsychiatry.2014.2656
  14. Browne HA, 2014, PSYCHIAT CLIN N AM, V37, P319, DOI 10.1016/j.psc.2014.06.002
  15. Cappi C, 2020, BIOL PSYCHIAT, V87, P1035, DOI 10.1016/j.biopsych.2019.09.029
  16. Cavazos TB, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2020.100017
  17. Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470
  18. Cullen B, 2007, DEPRESS ANXIETY, V24, P130, DOI 10.1002/da.20204
  19. de Mathis MA, 2013, EUR NEUROPSYCHOPHARM, V23, P594, DOI 10.1016/j.euroneuro.2012.08.006
  20. de Mathis MA, 2009, CNS SPECTRUMS, V14, P362, DOI 10.1017/S1092852900023014
  21. Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7
  22. do Rosario-Campos MC, 2005, AM J MED GENET B, V136B, P92, DOI 10.1002/ajmg.b.30149
  23. Fernandez Thomas V, 2018, Handb Clin Neurol, V148, P767, DOI 10.1016/B978-0-444-64076-5.00049-1
  24. Fonseca L, 2021, BRAZ J PSYCHIAT, V43, P631, DOI 10.1590/1516-4446-2020-1240
  25. Frías A, 2015, NEUROPSYCH DIS TREAT, V11, P2233, DOI 10.2147/NDT.S67636
  26. Fu JM, 2022, NAT GENET, V54, P1320, DOI 10.1038/s41588-022-01104-0
  27. Geller DA, 1998, HARVARD REV PSYCHIAT, V5, P260, DOI 10.3109/10673229809000309
  28. Gerdts JA, 2013, J AUTISM DEV DISORD, V43, P1597, DOI 10.1007/s10803-012-1706-6
  29. GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
  30. Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8
  31. Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979
  32. Halvorsen M, 2021, NAT NEUROSCI, V24, P1071, DOI 10.1038/s41593-021-00876-8
  33. Hanna GL, 2005, BIOL PSYCHIAT, V57, P895, DOI 10.1016/j.biopsych.2004.12.022
  34. Hasler G, 2007, BIOL PSYCHIAT, V61, P617, DOI 10.1016/j.biopsych.2006.05.040
  35. Hemmings SMJ, 2004, PSYCHIAT RES, V128, P175, DOI 10.1016/j.psychres.2004.05.007
  36. Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568
  37. Hirschtritt ME, 2017, JAMA-J AM MED ASSOC, V317, P1358, DOI 10.1001/jama.2017.2200
  38. Hoffmann TJ, 2014, JAMA PSYCHIAT, V71, P943, DOI 10.1001/jamapsychiatry.2014.420
  39. Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110
  40. Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9
  41. LaSalle VH, 2004, DEPRESS ANXIETY, V19, P163, DOI 10.1002/da.20009
  42. Leckman JE, 2010, DEPRESS ANXIETY, V27, P507, DOI 10.1002/da.20669
  43. Leckman JF, 2003, AM J MED GENET B, V116B, P60, DOI 10.1002/ajmg.b.10001
  44. Leppa VM, 2016, AM J HUM GENET, V99, P540, DOI 10.1016/j.ajhg.2016.06.036
  45. Mahjani B, 2022, AM J PSYCHIAT, V179, P216, DOI 10.1176/appi.ajp.2021.21010101
  46. Mahjani B, 2020, BIOL PSYCHIAT, V87, P1045, DOI 10.1016/j.biopsych.2020.01.006
  47. Mataix-Cols D, 2013, JAMA PSYCHIAT, V70, P709, DOI 10.1001/jamapsychiatry.2013.3
  48. Mathew CA, 2008, AM J MED GENET B, V147B, P676, DOI 10.1002/ajmg.b.30660
  49. Mathews CA, 2007, AM J MED GENET B, V144B, P174, DOI 10.1002/ajmg.b.30370
  50. Mattina GF, 2016, PROG NEURO-PSYCHOPH, V67, P107, DOI 10.1016/j.pnpbp.2016.01.012
  51. Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617
  52. Miguel EC, 2008, REV BRAS PSIQUIATR, V30, P185, DOI 10.1590/S1516-44462008000300003
  53. Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358
  54. Phillips KA, 2010, DEPRESS ANXIETY, V27, P528, DOI 10.1002/da.20705
  55. Rajagopal VM, 2022, NAT GENET, V54, P1117, DOI 10.1038/s41588-022-01143-7
  56. Riehm KE, 2023, WORLD PSYCHIATRY, V22, P160, DOI 10.1002/wps.21047
  57. Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585
  58. Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798
  59. Rougemont-Buecking A, 2008, PSYCHIAT RES, V157, P211, DOI 10.1016/j.psychres.2006.04.022
  60. Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572
  61. Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94
  62. Sanders S., 2013, Encyclopedia of Autism Spectrum Disorders
  63. Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036
  64. Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659
  65. Sirugo G, 2019, CELL, V177, P26, DOI [10.1016/j.cell.2019.02.048, 10.1016/j.cell.2019.04.032]
  66. Slomp C, 2018, CLIN GENET, V93, P830, DOI 10.1111/cge.13176
  67. Stein DJ, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0102-3
  68. Strom NI, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.711624
  69. Taylor S, 2011, CLIN PSYCHOL REV, V31, P1361, DOI 10.1016/j.cpr.2011.09.008
  70. Taylor S, 2011, CLIN PSYCHOL REV, V31, P1083, DOI 10.1016/j.cpr.2011.06.007
  71. Tükel R, 2002, COMPR PSYCHIAT, V43, P204, DOI 10.1053/comp.2002.32355
  72. Vandeleur CL, 2015, J AFFECT DISORDERS, V171, P120, DOI 10.1016/j.jad.2014.08.048
  73. Virkud YV, 2009, AM J MED GENET B, V150B, P328, DOI 10.1002/ajmg.b.30810
  74. Walter FM, 2005, ANN FAM MED, V3, P405, DOI 10.1370/afm.368
  75. Wang S, 2018, CELL REP, V24, P3441, DOI 10.1016/j.celrep.2018.08.082
  76. Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3
  77. Wroten M, 2023, CELL GENOM, V3, DOI 10.1016/j.xgen.2023.100319
  78. Yaryura-Tobias JA, 2000, J ANXIETY DISORD, V14, P19, DOI 10.1016/S0887-6185(99)00027-4
  79. Zhang JH, 2017, INT J MENT HEALTH SY, V11, DOI 10.1186/s13033-017-0127-5